These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25457816)

  • 1. Peripheral nervous system involvement in Parkinson's disease: evidence and controversies.
    Comi C; Magistrelli L; Oggioni GD; Carecchio M; Fleetwood T; Cantello R; Mancini F; Antonini A
    Parkinsonism Relat Disord; 2014 Dec; 20(12):1329-34. PubMed ID: 25457816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and features of peripheral neuropathy in Parkinson's disease patients under different therapeutic regimens.
    Mancini F; Comi C; Oggioni GD; Pacchetti C; Calandrella D; Coletti Moja M; Riboldazzi G; Tunesi S; Dal Fante M; Manfredi L; Lacerenza M; Cantello R; Antonini A
    Parkinsonism Relat Disord; 2014 Jan; 20(1):27-31. PubMed ID: 24099722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective assessment of peripheral neuropathy in Duodopa-treated parkinsonian patients.
    Merola A; Zibetti M; Rizzone MG; Troiano M; Artusi CA; Angrisano S; Cocito D; Lopiano L
    Acta Neurol Scand; 2014 Jan; 129(1):e1-5. PubMed ID: 23834498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small (autonomic) and large fiber neuropathy in Parkinson disease and parkinsonism.
    de Araújo DF; de Melo Neto AP; Oliveira ÍS; Brito BS; de Araújo IT; Barros IS; Lima JW; Horta WG; Gondim Fde A
    BMC Neurol; 2016 Aug; 16():139. PubMed ID: 27530902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral neuropathy in Parkinson's disease: levodopa exposure and implications for duodenal delivery.
    Müller T; van Laar T; Cornblath DR; Odin P; Klostermann F; Grandas FJ; Ebersbach G; Urban PP; Valldeoriola F; Antonini A
    Parkinsonism Relat Disord; 2013 May; 19(5):501-7 ; discussion 501. PubMed ID: 23453891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropathy as a potential complication of levodopa use in Parkinson's disease.
    Toth C; Brown MS; Furtado S; Suchowersky O; Zochodne D
    Mov Disord; 2008 Oct; 23(13):1850-9. PubMed ID: 18785232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropathy and levodopa in Parkinson's disease: evidence from a multicenter study.
    Ceravolo R; Cossu G; Bandettini di Poggio M; Santoro L; Barone P; Zibetti M; Frosini D; Nicoletti V; Manganelli F; Iodice R; Picillo M; Merola A; Lopiano L; Paribello A; Manca D; Melis M; Marchese R; Borelli P; Mereu A; Contu P; Abbruzzese G; Bonuccelli U
    Mov Disord; 2013 Sep; 28(10):1391-7. PubMed ID: 23836370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The peripheral nerve involvement in Parkinson Disease: A multifaceted phenomenon.
    Cossu G; Melis M
    Parkinsonism Relat Disord; 2016 Apr; 25():17-20. PubMed ID: 26857398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No association between neuropathy and restless legs in Parkinson's disease.
    Rajabally YA; Martey J
    Acta Neurol Scand; 2013 Mar; 127(3):216-20. PubMed ID: 22989006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levodopa responsiveness in disorders with parkinsonism: a review of the literature.
    Constantinescu R; Richard I; Kurlan R
    Mov Disord; 2007 Nov; 22(15):2141-8; quiz 2295. PubMed ID: 17534959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of rest tremor in Parkinson's disease.
    Budzianowska A; Honczarenko K
    Neurol Neurochir Pol; 2008; 42(1):12-21. PubMed ID: 18365958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levodopa affects functional brain networks in Parkinsonian resting tremor.
    Pollok B; Makhloufi H; Butz M; Gross J; Timmermann L; Wojtecki L; Schnitzler A
    Mov Disord; 2009 Jan; 24(1):91-8. PubMed ID: 18823037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral neuropathy in Parkinson's disease.
    Paul DA; Qureshi ARM; Rana AQ
    Neurol Sci; 2020 Oct; 41(10):2691-2701. PubMed ID: 32358706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do dyskinesia and pain share common pathophysiological mechanisms in Parkinson's disease?
    Lim SY; Farrell MJ; Gibson SJ; Helme RD; Lang AE; Evans AH
    Mov Disord; 2008 Sep; 23(12):1689-95. PubMed ID: 18709675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Entacapone, a catechol-O-methyltransferase inhibitor, improves the motor activity and dopamine content of basal ganglia in a rat model of Parkinson's disease induced by Japanese encephalitis virus.
    Hamaue N; Ogata A; Terado M; Tsuchida S; Yabe I; Sasaki H; Hirafuji M; Togashi H; Aoki T
    Brain Res; 2010 Jan; 1309():110-5. PubMed ID: 19879254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gait patterns in Parkinsonian patients with or without mild cognitive impairment.
    Amboni M; Barone P; Iuppariello L; Lista I; Tranfaglia R; Fasano A; Picillo M; Vitale C; Santangelo G; Agosti V; Iavarone A; Sorrentino G
    Mov Disord; 2012 Oct; 27(12):1536-43. PubMed ID: 23032876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Juvenile Parkinson's disease and recurring prematurity. Case report].
    Ha DE; Legendre G; Colau JC
    Gynecol Obstet Fertil; 2007 Mar; 35(3):224-7. PubMed ID: 17293151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral neuropathy in idiopathic Parkinson's disease: A systematic review.
    Zis P; Grünewald RA; Chaudhuri RK; Hadjivassiliou M
    J Neurol Sci; 2017 Jul; 378():204-209. PubMed ID: 28566165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levodopa in Parkinson's disease: from the past to the future.
    Pezzoli G; Zini M
    Expert Opin Pharmacother; 2010 Mar; 11(4):627-35. PubMed ID: 20163273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case series of peripheral neuropathy in patients with Parkinson's disease.
    Gondim Fde A; de Oliveira GR; Peixoto AA; Horta WG
    Ann Neurol; 2010 Dec; 68(6):973-5; author reply 975. PubMed ID: 21194162
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.